Advertisement

Ads Placeholder
Loading...

Genfit S.A.

GNFTFPNK
Healthcare
Biotechnology
$10.43
$0.00(0.00%)
U.S. Market opens in 4h 55m

Genfit S.A. Fundamental Analysis

Genfit S.A. (GNFTF) shows weak financial fundamentals with a PE ratio of -5.17, profit margin of -1.27%, and ROE of -5.96%. The company generates $0.1B in annual revenue with weak year-over-year growth of 1.35%.

Key Strengths

Cash Position19.43%
PEG Ratio0.05
Current Ratio2.00

Areas of Concern

ROE-5.96%
Operating Margin-84.23%
We analyze GNFTF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -578.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-578.7/100

We analyze GNFTF's fundamental strength across five key dimensions:

Efficiency Score

Weak

GNFTF struggles to generate sufficient returns from assets.

ROA > 10%
-54.44%

Valuation Score

Excellent

GNFTF trades at attractive valuation levels.

PE < 25
-5.17
PEG Ratio < 2
0.05

Growth Score

Weak

GNFTF faces weak or negative growth trends.

Revenue Growth > 5%
1.35%
EPS Growth > 10%
1.05%

Financial Health Score

Excellent

GNFTF maintains a strong and stable balance sheet.

Debt/Equity < 1
-6.37
Current Ratio > 1
2.00

Profitability Score

Weak

GNFTF struggles to sustain strong margins.

ROE > 15%
-596.06%
Net Margin ≥ 15%
-1.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is GNFTF Expensive or Cheap?

P/E Ratio

GNFTF trades at -5.17 times earnings. This suggests potential undervaluation.

-5.17

PEG Ratio

When adjusting for growth, GNFTF's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Genfit S.A. at -18.79 times its book value. This may indicate undervaluation.

-18.79

EV/EBITDA

Enterprise value stands at -65.53 times EBITDA. This is generally considered low.

-65.53

How Well Does GNFTF Make Money?

Net Profit Margin

For every $100 in sales, Genfit S.A. keeps $-1.27 as profit after all expenses.

-1.27%

Operating Margin

Core operations generate -84.23 in profit for every $100 in revenue, before interest and taxes.

-84.23%

ROE

Management delivers $-5.96 in profit for every $100 of shareholder equity.

-5.96%

ROA

Genfit S.A. generates $-54.44 in profit for every $100 in assets, demonstrating efficient asset deployment.

-54.44%

Following the Money - Real Cash Generation

Operating Cash Flow

Genfit S.A. generates limited operating cash flow of $-25.20M, signaling weaker underlying cash strength.

$-25.20M

Free Cash Flow

Genfit S.A. generates weak or negative free cash flow of $-26.59M, restricting financial flexibility.

$-26.59M

FCF Per Share

Each share generates $-0.53 in free cash annually.

$-0.53

FCF Yield

GNFTF converts -5.94% of its market value into free cash.

-5.94%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.17

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

-18.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.61

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-6.37

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-5.96

vs 25 benchmark

ROA

Return on assets percentage

-0.54

vs 25 benchmark

ROCE

Return on capital employed

-0.66

vs 25 benchmark

How GNFTF Stacks Against Its Sector Peers

MetricGNFTF ValueSector AveragePerformance
P/E Ratio-5.1728.23 Better (Cheaper)
ROE-596.06%737.00% Weak
Net Margin-127.38%-46175.00% (disorted) Weak
Debt/Equity-6.370.35 Strong (Low Leverage)
Current Ratio2.004.10 Neutral
ROA-54.44%-17785.00% (disorted) Weak

GNFTF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Genfit S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

59.98%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

101.70%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

123.47%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ